Morgan Stanley’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.26B | Buy |
|
|||||
|
2025
Q2 | $1.24B | Sell |
|
|||||
|
2025
Q1 | $1.95B | Buy |
|
|||||
|
2024
Q4 | $1.72B | Buy |
|
|||||
|
2024
Q3 | $1.45B | Buy |
|
|||||
|
2024
Q2 | $1.09B | Sell |
|
|||||
|
2024
Q1 | $1.59B | Sell |
|
|||||
|
2023
Q4 | $3.02B | Buy |
|
|||||
|
2023
Q3 | $2.13B | Buy |
|
|||||
|
2023
Q2 | $2.24B | Buy |
|
|||||
|
2023
Q1 | $2.31B | Sell |
|
|||||
|
2022
Q4 | $2.55B | Buy |
|
|||||
|
2022
Q3 | $2.1B | Sell |
|
|||||
|
2022
Q2 | $2.79B | Buy |
|
|||||
|
2022
Q1 | $2.01B | Buy |
|
|||||
|
2021
Q4 | $1.54B | Sell |
|
|||||
|
2021
Q3 | $1.48B | Buy |
|
|||||
|
2021
Q2 | $1.64B | Sell |
|
|||||
|
2021
Q1 | $1.63B | Buy |
|
|||||
|
2020
Q4 | $1.55B | Buy |
|
|||||
|
2020
Q3 | $1.28B | Buy |
|
|||||
|
2020
Q2 | $1.14B | Buy |
|
|||||
|
2020
Q1 | $1.01B | Sell |
|
|||||
|
2019
Q4 | $1.27B | Buy |
|
|||||
|
2019
Q3 | $678M | Buy |
|
|||||
|
2019
Q2 | $603M | Buy |
|
|||||
|
2019
Q1 | $615M | Sell |
|
|||||
|
2018
Q4 | $783M | Buy |
|
|||||
|
2018
Q3 | $830M | Buy |
|
|||||
|
2018
Q2 | $618M | Sell |
|
|||||
|
2018
Q1 | $926M | Sell |
|
|||||
|
2017
Q4 | $944M | Buy |
|
|||||
|
2017
Q3 | $898M | Sell |
|
|||||
|
2017
Q2 | $858M | Sell |
|
|||||
|
2017
Q1 | $1.12B | Buy |
|
|||||
|
2016
Q4 | $811M | Sell |
|
|||||
|
2016
Q3 | $1.11B | Buy |
|
|||||
|
2016
Q2 | $1.09B | Buy |
|
|||||
|
2016
Q1 | $903M | Sell |
|
|||||
|
2015
Q4 | $1B | Buy |
|
|||||
|
2015
Q3 | $811M | Buy |
|
|||||
|
2015
Q2 | $876M | Sell |
|
|||||
|
2015
Q1 | $904M | Sell |
|
|||||
|
2014
Q4 | $1.04B | Sell |
|
|||||
|
2014
Q3 | $913M | Sell |
|
|||||
|
2014
Q2 | $868M | Buy |
|
|||||
|
2014
Q1 | $831M | Buy |
|
|||||
|
2013
Q4 | $756M | Buy |
|
|||||
|
2013
Q3 | $644M | Sell |
|
|||||
|
2013
Q2 | $635M | Buy |
|